4.6 Article

Smart nanoparticles for drug delivery: Boundaries and opportunities

期刊

CHEMICAL ENGINEERING SCIENCE
卷 125, 期 -, 页码 158-164

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.ces.2014.06.042

关键词

Nanoparticle; Targeted drug delivery; Poorly soluble drug; Polymer micelle; Liposome; Nanocrystal

资金

  1. Showalter Research Trust Fund
  2. National Institute of Health [CA129287]

向作者/读者索取更多资源

Various pharmaceutical particles have been used in developing different drug delivery systems ranging from traditional tablets to state-of-the-art nanoparticle formulations. Nanoparticle formulations are unique in that the small size with huge surface area sometimes provides unique properties that larger particles and bulk materials do not have. Nanoparticle formulations have been used in improving the bioavailability of various drugs, in particular, poorly soluble drugs. Nanoparticle drug delivery systems have found their unique applications in targeted drug delivery to tumors. While nanoparticle formulations have been successful in small animal xenograft models, their translation to clinical applications has been very rare. Developing nanoparticle systems designed for targeted drug delivery. e.g., treating tumors in humans, requires clear understanding of the uniqueness of nanoparticles, as well as limitations and causes of failures in clinical applications. It also requires designing novel smart nanoparticle delivery systems that can increase the drug bioavailability and at the same time reduce the drug's side effects. (C) 2014 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据